Sinofn Health
Sinofn Health
In the age of Semantic Search and User Intent Mining, sourcing raw materials is no longer just about price. It is about "Information Gain"—the ability to prove efficacy, stability, and ethical transparency throughout the supply chain.
China has transitioned from a high-volume manufacturing hub to a global leader in Biotech Innovation. Factories like SINOFN leverage advanced fermentation and extraction technologies, providing a 40% efficiency gain over traditional methods while maintaining strict GMP compliance.
The industry is shifting toward Precision Nutrition. Demand is surging for NAD+ precursors (NMN), Bioactive Polysaccharides, and high-concentration plant-based Cyclic Adenosine Monophosphate (cAMP). Traceability through Blockchain is becoming a standard requirement for global enterprises.
From functional foods in Europe to FSMP (Foods for Special Medical Purposes) in Asia, our raw materials are designed for specific regulatory landscapes, ensuring seamless market entry for our global partners.
Science-Driven OEM for Global Supplement Brands
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences (CAS). Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
"We measure success not just in revenue, but in lives improved through accessible science." – Mrs. GuoHong Liu, Founder
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children – where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods. Her commitment attracted strategic investors and fueled transformative growth:
Our R&D department is led by postdoctoral fellows from the Chinese Academy of Sciences and Peking University Medical Doctorates.
Medical Innovation Director
Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
10+ dedicated lines for softgels, gummies, and powders. Annual capacity: 500M+ units.
HPLC/GC-MS screening, microbiological safety, and stability validation center.
Pilot-scale prototyping for tablets/capsules/liquids and bioavailability studies.
Raw material storage to packaging with blockchain-backed batch tracking.
For global enterprises, "Raw Material Factory" quality is synonymous with brand safety. SINOFN maintains ISO9001, ISO22000, HACCP, and HALAL certifications. We provide full documentation (COA, MSDS, Stability Data) to meet FDA, EFSA, and NMPA requirements.
We solve the "Innovation Gap" by offering pilot runs for new formulations. Our factory can scale from 10kg R&D batches to 10-ton commercial orders within weeks, significantly reducing Time-to-Market (TTM).
As a leading manufacturer, we implement green extraction technologies that reduce solvent waste by 60%. Our commitment to ESG principles ensures your brand meets the ethical expectations of modern consumers.
Beyond raw ingredients, we provide "Turnkey Solutions"—from ingredient sourcing to final product packaging (Softgels, Gummies, Sachet Powders, Oral Liquids).
Sinofn prioritizes intellectual property and safety, holding 36 patents and 71 trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to global quality and safety standards.
